https://www.mdpi.com/1999-4915/17/5/699
Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and...
A treatment-experienced, highly adherent person living with HIV for over 25 years developed resistance mutations against all four major ART classes, including...
https://adisinsight.springer.com/drugsafety/803857685?error=cookies_not_supported&code=63dfceb2-d89a-425a-bdc9-ec0f0f3acd55
Bictegravir/emtricitabine/tenofovir-alafenamide - AdisInsight
A 67-year-old man developed lactic acidosis following extra dose administration of bictegravir/emtricitabine/tenofovir-alafenamide for HIV infection [route,
tenofovir alafenamidebictegraviremtricitabineadisinsight
https://adisinsight.springer.com/drugsafety/803929035?error=cookies_not_supported&code=a0906757-44b8-4413-9397-30372200ac9f
Bictegravir/emtricitabine/tenofovir alafenamide/Methylprednisolone/Mycophenolate mofetil -...
A 31-year-old man with diffuse proliferative glomerulonephritis initially interpreted as class IV lupus nephritis had worsening to the point of requiring
tenofovir alafenamidebictegraviremtricitabinemethylprednisolonemycophenolate
https://www.mdpi.com/2036-7449/15/3/24
Bictegravir and Metformin Drug-Drug Interaction in People with Human Immunodeficiency Virus (HIV)
A drug-drug interaction (DDI) exists between bictegravir and metformin. Bictegravir inhibits renal organic cation transporter-2, leading to increased metformin...
human immunodeficiency virusdrug interaction
https://www.mdpi.com/2077-0383/12/24/7759
Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy...
Background: The aim of the study is to evaluate the effectiveness, safety, and tolerability of a two-drug regimen (2-DR) dolutegravir/lamivudine (DTG/3TC)...
tenofovir alafenamidedolutegravirlamivudineversus
https://adisinsight.springer.com/drugsafety/803927317?error=cookies_not_supported&code=efc7e97a-55d2-495f-8f4b-0e6f90705ee9
Bictegravir/emtricitabine/tenofovir alafenamide - AdisInsight
A patient [age not stated, sex not stated] with acquired immunodeficiency syndrome was exposed to Biktarvy [dose, route and duration not stated] and alcohol and
tenofovir alafenamidebictegraviremtricitabineadisinsight
https://adisinsight.springer.com/drugsafety/803923934?error=cookies_not_supported&code=4847d3fe-249d-4fee-8347-ca08e7b4b336
Bictegravir/Emtricitabine/Tenofovir alafenamide - AdisInsight
A report described people with HIV who experienced mild or moderate adverse drug reactions due to bictegravir, emtricitabine and tenofovir alafenamide, used as
tenofovir alafenamidebictegraviremtricitabineadisinsight
https://www.taffic.in/
TAFFIC HIV-1 Medicine | Bictegravir Emtricitabine Tenofovir Alafenamide
TAFFIC supports HIV-1 treatment using advanced antiretroviral therapy with Bictegravir, Emtricitabine and Tenofovir Alafenamide
hivmedicinebictegraviremtricitabinetenofovir